Skip to main content Accessibility help
×
Home

Sodium Valproate in Schizophrenia: Some Biochemical Correlates

  • A. Lautin (a1), B. Angrist (a1), M. Stanley (a1), S. Gershon (a1), K. Heckl (a1) and M. Karobath (a2)...

Summary

Sodium valproate given in doses of 750–3000 mg daily to eight schizophrenic patients produced a qualitatively similar increase in symptoms in five. CSF showed no significant change in γ-aminobutyric acid or methoxy hydroxyphenyl glycol, but homovanillic acid increased non-significantly in five patients.

Copyright

Corresponding author

Correspondence.

References

Hide All
Biggio, G., Casu, M., Corda, M. G., Vernaleone, F. & Gessa, G. L. (1977) Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain. Life Sciences, 21, 525–32.
Davis, K. E., Hollister, L. E. & Berger, P. A. (1976) Baclofen in schizophrenia. Lancet, i, 1245.
Dijkhuis, I. C. & Vervloet, E. (1974) Rapid determination of the antiepileptic drug di-n-propylacetic acid in serum. Pharmaceutisch Weekblad, 109, 42–5.
Enna, S. J. & Maggi, A. (1979) Biochemical pharmacology of GABA-ergic agonists. Life Sciences, 24, 1727–38.
Gibson, A. C. (1978) Sodium valproate and tardive dyskinesia. British Journal of Psychiatry, 133, 82.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. United States Department of Health, Education and Welfare. Publication No. (ADM) 76338.
Horton, R. W., Anzelark, G. M., Sawaza, M. C. B. & Meldrum, B. S. (1977) Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-o-sulfate. European Journal of Pharmacology, 41, 387–97.
Lautin, A., Stanley, M., Angrist, B. & Gershon, S. (1979) Extrapyramidal syndrome with sodium valproate. British Medical Journal, ii, 1035–6.
Linnoila, M., Viukari, M. & Hietala, O. (1976) Effect of sodium valproate on tardive dyskinesia. British Journal of Psychiatry, 129, 114–19.
Nagao, T., Ohshimo, T., Mitsunobu, K., Sato, M. & Otsuki, S. (1979) Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. Biological Psychiatry, 14, 509–23.
Nutt, J., Williams, A., Plotkin, C., Eng, N., Zeigler, M. & Calne, D. B. (1979) Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological and biochemical observations. Le Journal Canadien des Sciences Neurologiques, 6, 337–43.
Pinder, R. M., Brogden, R. N., Speight, T. M. & Avery, G. S. (1977) Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs, 13, 81123.
Scheel-Krüger, J., Arnt, J., Braestrup, C., Christensen, A. V., Cools, A. R. & Magelund, G. (1978a) GABA–Dopamine interaction in substantia nigra and nucleus accumbens: relevance to behavioral stimulation and stereotyped behavior. In Advances in Biochemical Pharmacology, Vol. 19 (ed. P. J. Roberts et al.) pp 343346. New York: Raven Press.
Scheel-Krüger, J., Arnt, J., Braestrup, C., Christensen, A. V., & Magelund, G. (1978b) Development of new animal models for GABA-ergic actions using muscimol as a tool. In GABA Neurotransmitters: Pharmachemical, Biochemical and Pharmacological Aspects (eds. P. Krogsgaard-Larsen, J. Scheel-Krüger and H. Kofod) Vol. 12, pp 447464, The Alfred Benson Symposium Series. Copenhagen: Munksgaard.
Schmid, R. & Karobath, M. (1977) Specific and sensitive method for the determination of γ-aminobutyric acid using gas chromatography with electron capture or mass fragmentographic detection. Journal of Chromatography, 139, 101–9.
Shoulson, I., Kartzinel, R. & Chase, T. N. (1976) Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid. Neurology, 26, 61–3.
Simpson, G. M., Branchey, M. H. & Shrivastava, R. K. (1976) Baclofen in schizophrenia. Lancet, 966–7.
Spitzer, R. L., Endicott, J. & Robbins, E. (1978) Research Diagnostic Criteria: rationale and reliability. Archives of General Psychiatry, 35, 773–82.
Tamminga, C. A., Crayton, J. W. & Chase, T. N. (1978) Muscimol: GABA agonist therapy in schizophrenia. American Journal of Psychiatry, 36, 595–8.
Waser, P. G. (1967) The pharmacology of Amanita muscarina. In Ethnopharmacologic Search for Psychoactive Drugs (eds. D. H. Efron, B. Holmsted and N. S. Kline). U.S. Public Health Service Publication, pp 419–39.
Watson, E. & Wilk, S. (1975) Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography. Psychopharmacologia (Berlin), 42, 5762.
Wilk, S., Davis, K. L. & Thacker, S. B. (1971) Determination of 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) in cerebrospinal fluid. Annals of Biochemistry, 39, 498504.
Worms, P. & Lloyd, K. G. (1978) Influence of GABA agonists and antagonists on neuroleptic-induced catalepsy in rats. Life Sciences, 23, 475–8.

Sodium Valproate in Schizophrenia: Some Biochemical Correlates

  • A. Lautin (a1), B. Angrist (a1), M. Stanley (a1), S. Gershon (a1), K. Heckl (a1) and M. Karobath (a2)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Sodium Valproate in Schizophrenia: Some Biochemical Correlates

  • A. Lautin (a1), B. Angrist (a1), M. Stanley (a1), S. Gershon (a1), K. Heckl (a1) and M. Karobath (a2)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *